Stock GLENMARK GLENMARK PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Delayed NSE India S.E.
Other stock markets
 12:43:53 20/06/2024 BST 		5-day change 1st Jan Change
1,241 INR +0.45% Intraday chart for Glenmark Pharmaceuticals Limited +1.34% +45.35%
06-12 India Equities Close Higher Ahead of US Inflation Data MT
06-12 Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
India Equities Close Higher Ahead of US Inflation Data
MT
Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules
MT
INDIA STOCKS-Metal stocks lead Indian shares higher
RE
Glenmark Pharmaceuticals Widens Consolidated Net Loss in Fiscal Q4
MT
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports
RE
Glenmark Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2025
CI
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Glenmark Pharmaceuticals Limited Recommends Dividend for the Financial Year 2023-24
CI
India's Sensex Ends Down, Nifty Up Ahead of National Poll Outcome
MT
Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India
MT
Glenmark Pharmaceuticals Receives ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%
CI
Glenmark Pharmaceuticals to Acquire 26% Stake in Renewable Energy Company
MT
Glenmark Pharmaceuticals Limited Receives Anda Approval for Acetaminophen and Ibuprofen Tablets, 250 Mg/125 Mg
CI
Glenmark Lifesciences' Net Profit Slides in Fiscal Q4
MT
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.
CI
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs
RE
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Glenmark Pharma, Pfizer Launch Atopic Dermatitis Oral Treatment in India
MT
Glenmark Pharmaceuticals Limited Partners with Pfizer to Launch Abrocitinib in India
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLENMARK Stock
  4. News Glenmark Pharmaceuticals Limited
  5. Highlights